Partner Expansion Partillion’s distribution partnership with Sony Biotechnology offers a potential route to broader customer reach. Business development teams could explore complementary distribution, co marketing, or integration opportunities that extend access to Nanovial based functional cell analysis.
Assay Development The 2025 Developer Kits give customers validated capture antibodies and standardized reagents for building custom assays and workflows. This creates an opportunity to engage biotech and pharmaceutical teams seeking faster assay setup, workflow customization, or technical support.
Platform Adoption Partillion trains researchers to run Nanovial assays on two commercial cell sorting platforms and has promoted the technology at cytometry events. Sales teams can target labs already using cell sorting and position training, implementation, and platform-compatible workflows as adoption support.
Research Credibility Nanovial technology has appeared in leading scientific journals and earned multiple awards, including the 2025 CYTO Innovation & Technology Showcase Award. This credibility can support outreach to organizations evaluating functional cell analysis for secretion, signaling, viability, and cell interaction studies.
Growth Potential With 11 to 50 employees, estimated revenue of $1 million to $10 million, and $6.1 million in funding, Partillion is a relatively small company building a specialized platform. Potential sales opportunities include scalable services and tools that support customer acquisition, laboratory operations, analytics, or commercial growth.